Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Laurence Reid

Director at Metagenomi Therapeutics, Inc. (MGX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$3K
Total bought / sold$23K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Sep 11SEC MGXMetagenomi Therapeutics, Inc. Buy 19,883new position $1.17 $23K -14.5%
Sep 11SEC MGXMetagenomi Therapeutics, Inc. Buy 11720,000 held (+1%) $1.18 $138 -15.3%
  • Buy

    Director Laurence Reid bought $23K of MGX at $1.17 — first open-market purchase in our records; opens a new position.